Isthmus Partners LLC Sells 23,408 Shares of Varex Imaging Co. (NASDAQ:VREX)

Isthmus Partners LLC lowered its stake in shares of Varex Imaging Co. (NASDAQ:VREX) by 13.6% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 148,614 shares of the company’s stock after selling 23,408 shares during the quarter. Isthmus Partners LLC owned 0.36% of Varex Imaging worth $1,771,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of VREX. Pzena Investment Management LLC grew its position in Varex Imaging by 51.4% in the 3rd quarter. Pzena Investment Management LLC now owns 3,890,879 shares of the company’s stock valued at $46,379,000 after acquiring an additional 1,321,666 shares during the last quarter. FMR LLC grew its position in Varex Imaging by 4,739.2% in the 3rd quarter. FMR LLC now owns 200,341 shares of the company’s stock valued at $2,388,000 after acquiring an additional 196,201 shares during the last quarter. Harbor Capital Advisors Inc. grew its position in Varex Imaging by 287.4% in the 2nd quarter. Harbor Capital Advisors Inc. now owns 165,103 shares of the company’s stock valued at $2,432,000 after acquiring an additional 122,488 shares during the last quarter. Rice Hall James & Associates LLC bought a new position in Varex Imaging in the 3rd quarter valued at $1,150,000. Finally, Deerfield Management Company L.P. Series C bought a new position in Varex Imaging in the 2nd quarter valued at $971,000.

Varex Imaging Stock Up 0.1 %

Shares of VREX stock opened at $16.53 on Friday. Varex Imaging Co. has a twelve month low of $10.19 and a twelve month high of $21.50. The stock has a fifty day simple moving average of $13.12 and a two-hundred day simple moving average of $13.52. The company has a current ratio of 3.32, a quick ratio of 1.97 and a debt-to-equity ratio of 0.72.

Analyst Upgrades and Downgrades

Several equities analysts have commented on VREX shares. StockNews.com raised Varex Imaging from a “hold” rating to a “buy” rating in a research report on Wednesday. B. Riley began coverage on Varex Imaging in a report on Friday, August 23rd. They issued a “buy” rating and a $21.00 target price for the company.

Varex Imaging Profile

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.